Results 141 to 150 of about 64,256 (179)
Some of the next articles are maybe not open access.
[Systemic mastocytosis and malignant mastocytosis].
Presse medicale (Paris, France : 1983), 1990Systemic mastocytosis is a rare, often undiagnosed disease characterized by the proliferation of mast cells in several tissues. The clinical symptoms are related to the mast cell infiltrates, but also to the release of numerous mediators. Malignant mastocytosis is a term that refers to two different entities: aggressive mastocytosis, where the outcome ...
O, Lortholary +4 more
openaire +1 more source
2016
Clinical History Image Findings Discussion Find Diagnosis Differential ...
openaire +1 more source
Clinical History Image Findings Discussion Find Diagnosis Differential ...
openaire +1 more source
Orvosi hetilap, 1997
The systemic mastocytosis is a rare disorder, however, the authors recently diagnosed two cases causing diagnostic problems. The diagnosis was proved by bone marrow biopsy in both patients. The authors review the diagnostic pathway considering the pitfalls.
T, Szabó +7 more
openaire +1 more source
The systemic mastocytosis is a rare disorder, however, the authors recently diagnosed two cases causing diagnostic problems. The diagnosis was proved by bone marrow biopsy in both patients. The authors review the diagnostic pathway considering the pitfalls.
T, Szabó +7 more
openaire +1 more source
Systemic mastocytosis and osteoporosis
Osteoporosis International, 1993A, Chines +4 more
openaire +2 more sources
La Revue du praticien, 2005
Systemic mastocytosis is characterized by mast cell proliferation in different organs. Classification delineates 4 categories: indolent systemic mastocytosis, systemic mastocytosis with an associated clonal hematologic non-mast cell lineage disease, aggressive systemic mastocytosis and mast cell leukaemia.
Olivier, Fain +2 more
openaire +1 more source
Systemic mastocytosis is characterized by mast cell proliferation in different organs. Classification delineates 4 categories: indolent systemic mastocytosis, systemic mastocytosis with an associated clonal hematologic non-mast cell lineage disease, aggressive systemic mastocytosis and mast cell leukaemia.
Olivier, Fain +2 more
openaire +1 more source
Tyrosine kinase inhibitors for the treatment of indolent systemic mastocytosis: Are we there yet?
Journal of Allergy and Clinical Immunology, 2022Cem Akin, Michel Arock, Peter Valent
exaly

